Iron Tartarate

Iron tartarate is a chelated iron supplement that combines ferrous iron with tartaric acid to enhance absorption. The tartaric acid acts as a chelating agent, forming stable complexes that may improve iron bioavailability compared to standard iron salts.

Origin & History

Iron tartrate is a mineral compound formed by chelating iron with tartaric acid, a naturally occurring organic acid found primarily in grapes and other fruits. It exists in two forms: ferrous tartrate (iron(II) tartrate, C₄H₆FeO₆) and ferric tartrate (iron(III) tartrate, C₁₂H₁₂Fe₂O₁₈), classified as beta hydroxy acid derivatives.

Historical & Cultural Context

No information regarding traditional or historical use of iron tartrate in medicine systems was provided in the available research sources.

Health Benefits

• Iron supplementation for nutritional support (evidence quality: not specified in available research)
• Enhanced mineral bioavailability through tartrate chelation (evidence quality: theoretical basis only)
• Potential iron deficiency support (evidence quality: no clinical trials provided)
• May support normal iron metabolism (evidence quality: no specific studies cited)
• Possible improved absorption compared to other iron forms (evidence quality: no comparative data available)

How It Works

Iron tartarate works through chelation, where tartaric acid forms coordinate bonds with ferrous iron ions, creating a stable complex that protects iron from precipitation in alkaline conditions. This chelated form may bypass some absorption inhibitors in the intestinal tract and facilitate transport across intestinal epithelial cells. Once absorbed, iron is incorporated into hemoglobin, myoglobin, and iron-containing enzymes involved in cellular energy production.

Scientific Research

The available research dossier contains no human clinical trials, randomized controlled trials, or meta-analyses evaluating iron tartrate efficacy or safety. The only referenced study is from 2013 in Acta Crystallographica focusing on iron(II) citrate coordination polymers' structural properties rather than clinical outcomes.

Clinical Summary

Limited clinical research exists specifically for iron tartarate compared to other iron forms. Most evidence supporting its use comes from general iron supplementation studies and theoretical chelation chemistry principles. No large-scale randomized controlled trials have directly compared iron tartarate to ferrous sulfate or other standard iron supplements. The evidence for enhanced bioavailability remains primarily theoretical, based on chelation chemistry rather than human clinical trials.

Nutritional Profile

Iron Tartarate is a chelated mineral salt compound formed by the coordination of iron (Fe) with tartaric acid (L-tartaric acid, C4H6O6). Primary active constituent is elemental iron, typically present at approximately 20-24% elemental iron by molecular weight in the ferrous tartrate form (FeTaO4·nH2O). The compound exists predominantly in the ferrous (Fe²⁺) oxidation state, which is the physiologically preferred form for intestinal absorption via DMT-1 (divalent metal transporter-1) in the duodenum and upper jejunum. Tartrate ligand contributes organic acid character (tartaric acid backbone) which maintains iron in solution at higher pH ranges compared to inorganic iron salts such as ferrous sulfate, theoretically improving solubility in the alkaline environment of the small intestine. No meaningful macronutrient contribution (negligible protein, fat, or carbohydrate content at supplemental doses). No dietary fiber content. No vitamin content inherent to the compound itself. Bioavailability is theoretically enhanced compared to ferric (Fe³⁺) salts due to chelation maintaining solubility, though direct comparative clinical bioavailability data versus ferrous sulfate or ferrous bisglycinate is limited in published literature. Tartrate component is metabolized via normal organic acid pathways and does not accumulate. Typical supplemental doses deliver 15-65 mg elemental iron per serving depending on formulation context.

Preparation & Dosage

No clinically studied dosage ranges for iron tartrate were found in the available research. Standardization information and dose-response data are not available. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Vitamin C, folic acid, vitamin B12, copper, vitamin B6

Safety & Interactions

Iron tartarate may cause typical iron supplement side effects including nausea, constipation, stomach upset, and dark stools. It can interact with tetracycline antibiotics, thyroid medications, and proton pump inhibitors, reducing their absorption. Concurrent use with calcium, zinc, or magnesium supplements may decrease iron absorption. Pregnant women should consult healthcare providers before use, as iron needs increase during pregnancy but excessive intake can be harmful.